Verition Fund Management
GOSS icon

Verition Fund Management’s Gossamer Bio GOSS Stock Holding History

Verition Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100,000
Closed -$83.3K – 2470
2023
Q3 		$83.3K Sell
100,000
-70,000
-41% -$80.7K ﹤0.01% 2137
2023
Q2 		$204K Buy
+170,000
New +$212K ﹤0.01% 1842

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Verition Fund Management's GOSS Position: Q4 2023 in Review

Verition Fund Management sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 100,000 shares — an estimated $83.3K sold.

Verition Fund Management first reported a position in GOSS in Q2 2023 and held it in 2 quarters. The position peaked at $204K in Q2 2023. 98 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

  • Verition Fund Management reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 100,000 Gossamer Bio shares in Q4 2023, an estimated $83.3K.
  • Verition Fund Management first reported a position in Gossamer Bio in Q2 2023 and held it in 2 quarters.
  • Verition Fund Management's Gossamer Bio position peaked at $204K in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.